heme-displacing IDO1 inhibitor

human predicted QD dose of 26 mg

from 260k MS-based screen and SBDD

ACS Med. Chem. Lett. Mar. 10, 2020

Merck, Boston, MA

Merck IDO1 inhibitor

Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: